REVVITY, INC Restructuring Charges
REVVITY, INC (RVTY) reported Restructuring Charges of $17.50 million for the 12-month period ending 2024-12-29, per its 10-K filed 2025-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2025-02-25
- REVVITY, INC restructuring charges for the quarter ending 2021-04-04 was $5.74M, a 1.95% decline year-over-year.
- REVVITY, INC restructuring charges for the quarter ending 2021-01-03 was -$3.06M, a 296.28% decline year-over-year.
- REVVITY, INC restructuring charges for the quarter ending 2020-10-04 was $4.06M, a 71.15% decline year-over-year.
- REVVITY, INC restructuring charges for the quarter ending 2020-07-05 was $1.16M, a 81.20% decline year-over-year.
- REVVITY, INC restructuring charges for fiscal 2024 was $17.50M, a 34.21% decline from fiscal 2023.
- REVVITY, INC restructuring charges for fiscal 2023 was $26.60M, a 95.59% increase from fiscal 2023.
- REVVITY, INC restructuring charges for fiscal 2023 was $13.60M.
- REVVITY, INC restructuring charges for fiscal 2022 was -$14.36M, a 287.42% decline from fiscal 2021.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 6 month as first filed | Restructuring Charges 9 month | Restructuring Charges 9 month as first filed | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-29 | $17.50M 10-K · filed 2025-02-25 | |||||||
| 2023-12-31 | $26.60M 10-K · filed 2025-02-25 | $26.60M 10-K · filed 2024-02-27 | ||||||
| 2023-01-01 | $13.60M 10-K · filed 2025-02-25 | -$13.58M 10-K · filed 2023-03-01 | ||||||
| 2022-01-02 | -$14.36M 10-K · filed 2024-02-27 | $16.43M 10-K · filed 2022-03-03 | ||||||
| 2021-04-04 | $5.74M 10-Q · filed 2021-05-11 | $2.68M derived: sum of 2 quarters · filed 2021-05-11 | $6.74M derived: sum of 3 quarters · filed 2021-05-11 | $7.90M derived: sum of 4 quarters · filed 2021-05-11 | ||||
| 2021-01-03 | -$3.06M 10-K · filed 2021-03-02 | $997.00K derived: sum of 2 quarters · filed 2021-03-02 | $2.15M derived: sum of 3 quarters · filed 2021-03-02 | $7.66M 10-K · filed 2023-03-01 | $8.01M 10-K · filed 2021-03-02 | |||
| 2020-10-04 | $4.06M 10-K · filed 2021-03-02 | $5.22M derived: sum of 2 quarters · filed 2021-03-02 | $10.66M 10-Q · filed 2020-11-10 | $12.63M derived: sum of 4 quarters · filed 2021-03-02 | ||||
| 2020-07-05 | $1.16M 10-K · filed 2021-03-02 | $6.80M 10-Q · filed 2020-08-11 | $8.58M derived: sum of 3 quarters · filed 2021-03-02 | $22.64M derived: sum of 4 quarters · filed 2021-03-02 | ||||
| 2020-04-05 | $5.86M 10-K · filed 2021-03-02 | $5.65M 10-Q · filed 2020-05-12 | $7.42M derived: sum of 2 quarters · filed 2021-03-02 | $21.49M derived: sum of 3 quarters · filed 2021-03-02 | $27.65M derived: sum of 4 quarters · filed 2021-03-02 | |||
| 2019-12-29 | $1.56M 10-K · filed 2021-03-02 | $15.63M derived: sum of 2 quarters · filed 2021-03-02 | $21.79M derived: sum of 3 quarters · filed 2021-03-02 | $29.43M 10-K · filed 2022-03-03 | ||||
| 2019-09-29 | $14.07M 10-K · filed 2021-03-02 | $20.23M derived: sum of 2 quarters · filed 2021-03-02 | $27.25M 10-Q · filed 2019-11-05 | $25.93M derived: sum of 4 quarters · filed 2021-03-02 | ||||
| 2019-06-30 | $6.16M 10-K · filed 2021-03-02 | $13.45M 10-Q · filed 2019-08-06 | $11.86M derived: sum of 3 quarters · filed 2021-03-02 | $18.37M derived: sum of 4 quarters · filed 2021-03-02 | ||||
| 2019-03-31 | $7.64M 10-K · filed 2021-03-02 | $7.46M 10-Q · filed 2019-05-07 | $5.70M derived: sum of 2 quarters · filed 2021-03-02 | $12.21M derived: sum of 3 quarters · filed 2021-03-02 | $12.21M derived: sum of 4 quarters · filed 2021-03-02 | |||
| 2018-12-30 | -$1.94M 10-K · filed 2020-02-25 | $4.57M derived: sum of 2 quarters · filed 2020-02-25 | $4.57M derived: sum of 3 quarters · filed 2020-02-25 | $11.14M 10-K · filed 2021-03-02 | ||||
| 2018-09-30 | $6.51M 10-K · filed 2020-02-25 | $6.51M derived: sum of 2 quarters · filed 2020-02-25 | $12.51M 10-Q · filed 2018-11-06 | $12.82M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-07-01 | $0.00 10-K · filed 2020-02-25 | $6.00M 10-Q · filed 2018-08-07 | $6.32M derived: sum of 3 quarters · filed 2020-02-25 | $9.58M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-04-01 | $6.58M 10-K · filed 2020-02-25 | $6.00M 10-Q · filed 2018-05-08 | $6.32M derived: sum of 2 quarters · filed 2020-02-25 | $9.58M derived: sum of 3 quarters · filed 2020-02-25 | $9.58M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | -$263.00K 10-K · filed 2019-02-26 | $3.01M derived: sum of 2 quarters · filed 2019-02-26 | $3.01M derived: sum of 3 quarters · filed 2019-02-26 | $12.66M 10-K · filed 2020-02-25 | ||||
| 2017-10-01 | $3.27M 10-K · filed 2019-02-26 | $3.27M derived: sum of 2 quarters · filed 2019-02-26 | $12.88M 10-Q · filed 2017-11-07 | $12.92M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-07-02 | $0.00 10-K · filed 2019-02-26 | $9.61M 10-Q · filed 2017-08-08 | $9.65M derived: sum of 3 quarters · filed 2019-02-26 | $10.31M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-04-02 | $9.65M 10-K · filed 2019-02-26 | $9.61M 10-Q · filed 2017-05-09 | $9.65M derived: sum of 2 quarters · filed 2019-02-26 | $10.31M derived: sum of 3 quarters · filed 2019-02-26 | $14.78M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-01-01 | $0.00 10-K · filed 2018-02-27 | $656.00K derived: sum of 2 quarters · filed 2018-02-27 | $5.12M derived: sum of 3 quarters · filed 2018-02-27 | $5.12M 10-K · filed 2019-02-26 | ||||
| 2016-10-02 | $656.00K 10-K · filed 2018-02-27 | $5.12M derived: sum of 2 quarters · filed 2018-02-27 | $7.11M 10-Q · filed 2016-11-08 | $13.88M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-07-03 | $4.47M 10-K · filed 2017-02-28 | $4.47M 10-K · filed 2018-02-27 | $5.29M 10-Q · filed 2016-08-09 | $13.22M derived: sum of 3 quarters · filed 2018-02-27 | $13.11M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-04-03 | $0.00 10-K · filed 2018-02-27 | $8.75M derived: sum of 2 quarters · filed 2018-02-27 | $8.64M derived: sum of 3 quarters · filed 2018-02-27 | $13.55M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-01-03 | $8.75M 10-K · filed 2017-02-28 | $8.64M derived: sum of 2 quarters · filed 2017-02-28 | $13.55M derived: sum of 3 quarters · filed 2017-02-28 | $13.55M 10-K · filed 2018-02-27 | $13.59M 10-K · filed 2016-03-01 | |||
| 2015-10-04 | -$115.00K 10-K · filed 2017-02-28 | -$118.00K 10-K · filed 2016-03-01 | $4.79M derived: sum of 2 quarters · filed 2017-02-28 | $6.04M 10-Q · filed 2015-11-10 | $4.22M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-28 | $4.91M 10-K · filed 2017-02-28 | $4.96M 10-K · filed 2016-03-01 | $6.04M 10-Q · filed 2015-08-04 | $4.33M derived: sum of 3 quarters · filed 2017-02-28 | $15.42M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-29 | $0.00 10-K · filed 2017-02-28 | -$579.00K derived: sum of 2 quarters · filed 2017-02-28 | $10.51M derived: sum of 3 quarters · filed 2017-02-28 | $11.26M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-28 | -$579.00K 10-K · filed 2016-03-01 | $10.51M derived: sum of 2 quarters · filed 2016-03-01 | $11.26M derived: sum of 3 quarters · filed 2016-03-01 | $13.32M 10-K · filed 2017-02-28 | $13.39M 10-K · filed 2015-02-24 | |||
| 2014-09-28 | $11.09M 10-K · filed 2016-03-01 | $11.83M derived: sum of 2 quarters · filed 2016-03-01 | $13.97M 10-Q · filed 2014-11-04 | $24.18M derived: sum of 4 quarters · filed 2016-03-01 | ||||
| 2014-06-29 | $742.00K 10-K · filed 2016-03-01 | $2.88M 10-Q · filed 2014-08-05 | $13.09M derived: sum of 3 quarters · filed 2016-03-01 | $14.21M derived: sum of 4 quarters · filed 2016-03-01 | ||||
| 2014-03-30 | $2.13M 10-K · filed 2016-03-01 | $12.35M derived: sum of 2 quarters · filed 2016-03-01 | $13.47M derived: sum of 3 quarters · filed 2016-03-01 | $32.72M derived: sum of 4 quarters · filed 2016-03-01 | ||||
| 2013-12-29 | $10.21M 10-K · filed 2015-02-24 | $10.21M 10-K · filed 2014-02-25 | $11.34M derived: sum of 2 quarters · filed 2015-02-24 | $30.58M derived: sum of 3 quarters · filed 2015-02-24 | $33.89M 10-K · filed 2016-03-01 | $33.93M 10-K · filed 2014-02-25 | ||
| 2013-09-29 | $1.12M 10-K · filed 2015-02-24 | $1.13M 10-Q · filed 2013-11-05 | $20.37M derived: sum of 2 quarters · filed 2015-02-24 | $23.68M 10-Q · filed 2014-11-04 | $23.71M 10-Q · filed 2013-11-05 | $27.78M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $19.25M 10-K · filed 2015-02-24 | $19.28M 10-Q · filed 2013-08-06 | $22.56M 10-Q · filed 2014-08-05 | $22.59M 10-Q · filed 2013-08-06 | $26.66M derived: sum of 3 quarters · filed 2015-02-24 | $36.33M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $3.31M 10-K · filed 2015-02-24 | $7.41M derived: sum of 2 quarters · filed 2015-02-24 | $17.09M derived: sum of 3 quarters · filed 2015-02-24 | $22.29M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-30 | $4.10M 10-K · filed 2014-02-25 | $13.78M derived: sum of 2 quarters · filed 2014-02-25 | $18.98M derived: sum of 3 quarters · filed 2014-02-25 | $25.05M 10-K · filed 2015-02-24 | $25.14M 10-K · filed 2013-02-26 | |||
| 2012-09-30 | $9.67M 10-K · filed 2014-02-25 | $14.88M derived: sum of 2 quarters · filed 2014-02-25 | $21.03M 10-Q · filed 2013-11-05 | $31.15M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-07-01 | $5.20M 10-K · filed 2014-02-25 | $11.36M 10-Q · filed 2013-08-06 | $21.47M derived: sum of 3 quarters · filed 2014-02-25 | $21.47M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-04-01 | $6.16M 10-K · filed 2014-02-25 | $16.27M derived: sum of 2 quarters · filed 2014-02-25 | $16.27M derived: sum of 3 quarters · filed 2014-02-25 | $19.61M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-01-01 | $10.11M 10-K · filed 2013-02-26 | $10.11M derived: sum of 2 quarters · filed 2013-02-26 | $13.45M derived: sum of 3 quarters · filed 2013-02-26 | $13.45M 10-K · filed 2014-02-25 | ||||
| 2011-10-02 | $0.00 10-K · filed 2013-02-26 | $3.34M derived: sum of 2 quarters · filed 2013-02-26 | $3.34M 10-Q · filed 2012-11-06 | $12.47M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-07-03 | $3.34M 10-K · filed 2013-02-26 | $3.34M 10-Q · filed 2012-08-07 | $12.47M derived: sum of 3 quarters · filed 2013-02-26 | $12.47M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-04-03 | $0.00 10-K · filed 2013-02-26 | $9.13M derived: sum of 2 quarters · filed 2013-02-26 | $9.13M derived: sum of 3 quarters · filed 2013-02-26 | $18.96M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-01-02 | $9.13M 10-K · filed 2012-02-28 | $9.13M derived: sum of 2 quarters · filed 2012-02-28 | $18.96M derived: sum of 3 quarters · filed 2012-02-28 | $18.96M 10-K · filed 2013-02-26 | ||||
| 2010-10-03 | $0.00 10-K · filed 2012-02-28 | $9.83M derived: sum of 2 quarters · filed 2012-02-28 | $9.83M 10-Q · filed 2011-11-04 | $9.83M derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-07-04 | $9.83M 10-K · filed 2012-02-28 | $9.85M 10-Q · filed 2010-08-10 | $9.83M 10-Q · filed 2011-08-10 | $9.85M 10-Q · filed 2010-08-10 | $9.83M derived: sum of 3 quarters · filed 2012-02-28 | $20.63M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-04-04 | $0.00 10-K · filed 2012-02-28 | $0.00 derived: sum of 2 quarters · filed 2012-02-28 | $10.80M derived: sum of 3 quarters · filed 2012-02-28 | |||||
| 2010-01-03 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $10.80M derived: sum of 2 quarters · filed 2012-02-28 | $17.99M 10-K · filed 2012-02-28 | |||||
| 2009-10-04 | $10.80M 10-Q · filed 2010-11-10 | $17.99M 10-Q · filed 2010-11-10 | ||||||
| 2009-07-05 | $7.85M 10-Q · filed 2010-08-10 | |||||||
| 2008-12-28 | $6.67M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |